These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 21568074

  • 1. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M, Mataija M, Sović D, Dodig J, Matijević R, Kukuruzović M.
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [Abstract] [Full Text] [Related]

  • 2. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A, Brossard Y.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [Abstract] [Full Text] [Related]

  • 3. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E, Westgren M, Pasupathy D, Karlsson A, Wikman AT.
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [Abstract] [Full Text] [Related]

  • 4. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM, de Haas M, Vrijkotte TG, Bonsel GJ, van der Schoot CE.
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [Abstract] [Full Text] [Related]

  • 5. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G, Sheiner E, Levy A, Erez O, Mazor M.
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [Abstract] [Full Text] [Related]

  • 6. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J, Tappenden P, Lloyd Jones M, Wight J, Forman K, Wray J, Beverley C.
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ.
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Sherwood MR, Clayton S, Leeper CM, Yazer M, Moise KJ, Granger ME, Spinella PC.
    Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
    [Abstract] [Full Text] [Related]

  • 11. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
    Branch DR, Scofield TL, Moulds JJ, Swanson JL.
    Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
    [Abstract] [Full Text] [Related]

  • 12. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD, Gordon MC, Higby K.
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [Abstract] [Full Text] [Related]

  • 13. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A, Brossard Y, Beliard R, Bourel D.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P, Lardennois C, Galène-Gromez S, Brossard V, Marpeau L, Verspyck E, Marret S, le Réseau de périnatalité de Haute-Normandie.
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [Abstract] [Full Text] [Related]

  • 16. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
    Sainio S, Kuosmanen M.
    Duodecim; 2012 Oct; 128(2):151-7. PubMed ID: 22372070
    [Abstract] [Full Text] [Related]

  • 17. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
    Seeho SK, Burton G, Leigh D, Marshall JT, Persson JW, Morris JM.
    Hum Reprod; 2005 Mar; 20(3):697-701. PubMed ID: 15661826
    [Abstract] [Full Text] [Related]

  • 18. Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D- pregnant women.
    Clausen FB.
    Immunohematology; 2024 Apr 01; 40(1):15-27. PubMed ID: 38739027
    [Abstract] [Full Text] [Related]

  • 19. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R, Shokri F.
    Iran J Immunol; 2008 Dec 01; 5(4):189-200. PubMed ID: 19098362
    [Abstract] [Full Text] [Related]

  • 20. Management of red cell alloimmunisation in pregnancy: the non-invasive monitoring of the disease.
    Illanes S, Soothill P.
    Prenat Diagn; 2010 Jul 01; 30(7):668-73. PubMed ID: 20572110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.